Employers pull back on covering weight-loss drugs as Wegovy, Zepbound costs strain budgets, Washington Post reports

More employers are dropping or scaling back coverage of weight-loss drugs such as Wegovy and Zepbound as the price strains company health-care budgets, the Washington Post reports.

Detected & updated continuously · Source: Nebula